Godfrey Financial Associates’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Godfrey Financial Associates’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.3K	Buy	+71	New	+$14.7K	0.01%	381

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Godfrey Financial Associates's FBT Position: Q1 2026 in Review

Godfrey Financial Associates opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026: 71 shares worth $14.3K. The stake represents 0.01% of the portfolio and ranks #381 among its holdings.

307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Godfrey Financial Associates held 71 shares of First Trust NYSE Arca Biotechnology Index Fund worth $14.3K as of Q1 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new Godfrey Financial Associates position in Q1 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Godfrey Financial Associates's portfolio in Q1 2026, its #381 holding.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Godfrey Financial Associates's 13F filing for Q1 2026, filed 12 May 2026.